IFNAR2 - interferon alpha and beta receptor subunit 2 Gene
Also Known as IFN-R; IMD45; IFNABR; IFNARB; IFN-alpha-REC
Species: Homo sapiens
About IFNAR2
This gene has 14 transcripts (splice variants), 303 orthologues, 11 paralogues and is associated with 3 phenotypes. Ubiquitous expression in spleen (RPKM 13.0), appendix (RPKM 12.7) and 24 other tissues.
Summary
The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020]
IFNAR2 Products (8)
| mRNA | Protein | Name |
|---|---|---|
| NM_000874.5 | NP_000865.2 | interferon alpha/beta receptor 2 isoform b |
| NM_001385055.1 | NP_001371984.1 | interferon alpha/beta receptor 2 isoform e |
| NM_001385054.1 | NP_001371983.1 | interferon alpha/beta receptor 2 isoform d |
| NM_001289128.2 | NP_001276057.1 | interferon alpha/beta receptor 2 isoform c |
| NM_207584.3 | NP_997467.1 | interferon alpha/beta receptor 2 isoform b |
| NM_207585.3 | NP_997468.1 | interferon alpha/beta receptor 2 isoform a |
| NM_001289125.3 | NP_001276054.1 | interferon alpha/beta receptor 2 isoform a |
| NM_001289126.2 | NP_001276055.1 | interferon alpha/beta receptor 2 isoform c |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables cytokine binding |
IPI
IPI: Inferred from physical interaction
|
8798579 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
7665574 | GOA |
| enables protein kinase binding |
IPI
IPI: Inferred from physical interaction
|
7759950 | GOA |
| enables type I interferon binding |
IPI
IPI: Inferred from physical interaction
|
7759950 | GOA |
| enables type I interferon receptor activity |
IDA
IDA: Inferred from direct assay
|
7665574 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in cell surface receptor signaling pathway via JAK-STAT |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
| involved in cellular response to interferon-beta |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
| involved in defense response to virus |
IMP
IMP: Inferred from mutant phenotype
|
26424569 | GOA |
| involved in response to interferon-alpha |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
| involved in response to interferon-alpha |
IMP
IMP: Inferred from mutant phenotype
|
26424569 | GOA |
| involved in response to interferon-beta |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
| involved in response to interferon-beta |
IMP
IMP: Inferred from mutant phenotype
|
26424569 | GOA |
| involved in type I interferon-mediated signaling pathway |
IDA
IDA: Inferred from direct assay
|
7665574 | GOA |
| involved in type I interferon-mediated signaling pathway |
IMP
IMP: Inferred from mutant phenotype
|
26424569 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
7759950 | GOA |
IFNAR2 Protein Structure
Tissue_fac: Tissue factor (12 - 118)
Interfer-bind: Interferon-alpha/beta receptor, fibronectin type III (133 - 229)
- 0
- 100
- 200
- 300
- 400
- 515 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
interferon alpha/beta receptor 2 |
|
|
IFNAR2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
IFNAR2 | P48551 | STAT1 | Homo sapiens | P42224 | 9121453 | |
|
Intra
|
IFNAR2 | P48551 | JAK1 | Homo sapiens | P23458 | 16710296 | |
|
Intra
|
IFNAR2 | P48551 | JAK1 | Homo sapiens | P23458 | 16710296 | |
|
Intra
|
IFNAR2 | P48551 | STAT2 | Homo sapiens | P52630 | 9121453 | |
|
Intra
|
IFNAR2 | P48551 | STAT2 | Homo sapiens | P52630 | 17923090 | |
|
Intra
|
IFNAR2 | P48551 | STAT2 | Homo sapiens | P52630 | 17923090 | |
|
Intra
|
IFNAR2 | P48551 | RACK1 | Homo sapiens | P63244 | 11046044 | |
|
Intra
|
IFNAR2 | P48551 | RACK1 | Homo sapiens | P63244 | 11046044 | |
|
Intra
|
IFNAR2 | P48551 | USP18 | Homo sapiens | Q9UMW8 | 16710296 | |
|
Intra
|
IFNAR2 | P48551 | IFNA2 | Homo sapiens | P01563 | 21854986 | |
|
Intra
|
IFNAR2 | P48551 | IRF9 | Homo sapiens | Q00978 | 17923090 | |
|
Intra
|
IFNAR2 | P48551 | IRF9 | Homo sapiens | Q00978 | 17923090 | |
|
Intra
|
IFNAR2 | P48551 | PDLIM1 | Homo sapiens | O00151 | 33961781 | |
|
Intra
|
IFNAR2 | P48551 | CREBBP | Homo sapiens | Q92793 | 17923090 | |
|
Intra
|
IFNAR2 | P48551 | CREBBP | Homo sapiens | Q92793 | 17923090 |
Recombinant IFNAR2 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72613 | IFN-alpha/beta R2 Protein, Human (HEK293, His) | P48551-1 (I27-K243) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P74860 | IFN-alpha/beta R2 Protein, Human (HEK293, hFc) | P48551-1 (I27-K243) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P74861 | IFN-alpha/beta R2 Protein, Human (Biotinylated, HEK293, His) | P48551-1 (I27-K243) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P74862A | IFN-alpha/beta R2 Protein, Human (HEK293, His, solution) | P48551-1 (I27-K243) | ≥ 95%, as determined by reducing SDS-PAGE. |
IFNAR2 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P811166 | IFNAR2 Antibody | WB, IHC-P | Human, Mouse, Rat |
| HY-P89824 | IFNAR2 Antibody (YA9168) | WB, ICC/IF, IF-Tissue, IP, ELISA | human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Multiple Sclerosis |
|
|
| Hepatitis C |
|
|
| Multisystem Inflammatory Syndrome In Children |
|
|
| Immunodeficiency 28 |
|
|
| Torch Syndrome |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
| Immunodeficiency 45 |
|
|
| Rubella |
|
|
| Immunodeficiency 44 |
|
|
| Viral Infectious Disease |
|
|
| Herpangina |
|
|
| Immunodeficiency 39 |
|
|
| Aicardi-Goutieres Syndrome |
|
|
| Mumps |
|
|
| West Nile Encephalitis |
|
|
| Hepatitis B |
|
|
| Primary Immunodeficiency With Post-Measles-Mumps-Rubella Vaccine Viral Infection |
|
|
| Measles |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | IFNAR2 | VGNC | VGNC:30055 |
| Rattus norvegicus | IFNAR2 | RGD | RGD:1583177 |
| Macaca mulatta | IFNAR2 | VGNC | VGNC:81330 |
| Felis catus | IFNAR2 | VGNC | VGNC:103734 |
| Mus musculus | IFNAR2 | MGD | MGI:1098243 |
| Others | IFNAR2 | NCBI |